Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension to Evaluate the Safety and Efficacy of Pregabalin for Treatment of Chronic Central Neuropathic Pain After Spinal Cord Injury.

NCT00141375 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00141375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension to Evaluate the Safety and Efficacy of Pregabalin for Treatment of Chronic Central Neuropathic Pain After Spinal Cord Injury.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
January 31, 2006
Enrollment
132
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain